Synta Pharmaceuticals Corp (NASDAQ:SNTA)

1.94
Delayed Data
As of Mar 31
 -0.39 / -16.74%
Today’s Change
1.85
Today|||52-Week Range
4.97
-26.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-47.4M-62.8M-90.2M--
 
 
 
 
Depreciation1.5M738.0K516.0K--
 
 
 
 
Total Other Cash Flow3.4M3.3M6.0M--
 
 
 
 
Funds From Operations-42.6M-58.7M-83.6M--
 
 
 
 
Funds From/For Other Operating Expenses4.7M-4.6M-6.2M--
 
 
 
 
Net Cash Flow - Operating Activities-47.3M-54.1M-77.4M--
 
 
 
 
 
InvestingIncrease In Investments-50.7M-50.0M-114.2M--
 
 
 
 
Decrease In Investments60.7M40.6M90.3M--
 
 
 
 
Capital Expenditures-690.0K-505.0K-769.0K--
 
 
 
 
Net Cash Flow Investing9.3M-9.9M-24.7M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings2.0M0.0013.5M--
 
 
 
Long Term Debt Reduction-579.0K-4.2M-2.6M--
 
 
 
 
Net Proceeds Stock Sale35.3M119.8M58.2M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.0032.0K0.00--
 
 
Net Cash Flow - Financing36.7M115.5M69.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-1.2M51.4M-33.0M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account